Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 908 K1.01 M1.02 M1.04 M1.1 M1.27 M 4.42 M Research & development 252 K246 K214 K237 K294 K274 K 1.02 M Operating income 30 K-169 K-2 000181 K-8 000-218 K -47 K Non-Operating Income, Total 98 K88 K82 K91 K84 K71 K 328 K Interest expense, net of interest capitalized 0-6 0006 00006 0003 000 15 K Non-Operating Income, excl. Interest Expenses 98 K94 K76 K91 K78 K68 K 313 K Unusual income/expense —————— — Pretax income 128 K-81 K80 K272 K76 K-147 K 281 K Equity in earnings —————— — Taxes -73 K-17 K21 K64 K-27 K-31 K 27 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 201 K-64 K59 K208 K103 K-116 K 254 K Discontinued operations —————— — Net income 201 K-64 K59 K208 K103 K-116 K 254 K Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 201 K-64 K59 K208 K103 K-116 K 254 K Basic earnings per share (Basic EPS) 0.06-0.020.020.060.03-0.03 0.08 Diluted earnings per share (Diluted EPS) 0.06-0.020.020.060.03-0.03 0.08 Average basic shares outstanding 3.44 M3.45 M3.45 M3.46 M3.46 M3.51 M — Diluted shares outstanding 3.44 M3.45 M3.55 M3.47 M3.48 M3.51 M — EBITDA 52 K-146 K20 K204 K13 K-197 K 40 K EBIT 30 K-169 K-2 000181 K-8 000-218 K -47 K Cost of revenue 1.21 M1.16 M1.17 M1.29 M1.37 M1.26 M 5.09 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 22 K23 K22 K23 K21 K21 K 87 K